Embecta Corp

NASDAQ EMBC

Download Data

Embecta Corp Gross Working Capital 1 year YoY Change (%) for the year ending September 30, 2023: 9.10%

Embecta Corp Gross Working Capital 1 year YoY Change (%) is 9.10% for the year ending September 30, 2023, a -94.83% change year over year. Gross working capital is a financial metric that represents the amount of a company's current assets available to cover its current liabilities and short-term debt obligations. It is calculated by subtracting the sum of current liabilities and short-term debt from the total current assets of a company. Gross working capital provides insights into a company's short-term liquidity and its ability to meet its financial obligations in the near future. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
  • Embecta Corp Gross Working Capital for the year ending September 30, 2022 was USD 350.60 M, a 176.06% change year over year.
  • Embecta Corp Gross Working Capital for the year ending September 30, 2021 was USD 127.00 M, a 30.93% change year over year.
  • Embecta Corp Gross Working Capital for the year ending September 30, 2020 was USD 97.00 M.
NASDAQ: EMBC

Embecta Corp

CEO Mr. Devdatt Kurdikar
IPO Date April 1, 2022
Location United States
Headquarters 300 Kimball Drive, Parsippany, NJ, United States, 07054
Employees 2,200
Sector Healthcare
Industry Medical instruments & supplies
Description

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Similar companies

ANGO

AngioDynamics Inc

NA

NA

AKYA

Akoya Biosciences Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email